Symbol
INZY
Investment type
Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned
0 shares
Security Ownership %
0%

Pivotal bioVenture Partners Fund I, L.P. ownership in Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share (INZY)

27 Aug 2025 - Pivotal bioVenture Partners Fund I, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share (INZY). This represents 0% ownership of the company. This is the first filing by Pivotal bioVenture Partners Fund I, L.P. disclosing ownership of Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share (INZY).